Effects of serum and plasma from hemodialysis patients on the lymphoproliferative response.
The effect of serum and plasma from hemodialysis patients on the immune response was investigated in vitro using phytohemagglutinin(PHA)-, concanavalin A(Con A)-, and staphage lysate(SPL)-induced and spontaneous blastogenesis of peripheral lymphocytes from a healthy person. An immunosuppressive substance(s) was found to exist in these samples and markedly increased in activity after hemodialysis. This substances(s) was heat-labile (56 degrees C, 30 min) and had a molecular weight of 50,000 daltons or more. It was not related to heparin. The appearance of this substance(s) was not influenced by the patients' sex or age or by the duration of hemodialysis.
D003165:Complement System Proteins / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007700:Kinetics; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D008970:Molecular Weight; D010949:Plasma / Q000032:analysis; D006435:Renal Dialysis; D012737:Sex Factors; D014511:Uremia / Q000097:blood*
D007106:Immune Sera; D007166:Immunosuppressive Agents; D003165:Complement System Proteins